FEBRUARY 19, 2016 BY BRAD PERRIELLO NuVasive Inc. (NSDQ:NUVA) this week won a round in its long-standing intellectual property feud with Medtronic (NYSE:MDT) when a federal judge in California found that a patent covering NuVasive’s Osteocel Plus bone matrix does not infringe Medtronic’s IP. Medtronic’s Warsaw unit sued NuVasive in August 2012 in the U.S. District Court for Southern California, alleging that […]